Cargando…
Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management
Immune checkpoint inhibitors (ICIs) target programmed cell death (PD) 1 receptor and its ligand PD-L1, and have become an integral part of treatment regimens in many cancers including lung cancer, renal cell carcinoma, melanoma, and more. Cancer is associated with a significantly increased risk of v...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047296/ https://www.ncbi.nlm.nih.gov/pubmed/36975443 http://dx.doi.org/10.3390/curroncol30030230 |